Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ROQ Roquefort Therapeutics Plc

2.30
0.00 (0.00%)
18 Feb 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Roquefort Therapeutics Plc LSE:ROQ London Stock Exchange Ordinary Share GB00BMDQ2T15 ORD 1P
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time   RN  NRN 
   0.00 0.00 2.30 2.20 2.40 2.30 2.30 2.3 344,253 08:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Cmp Integrated Sys Design 200k -1.75M -0.0135 -1.70 2.97M
 Type  Size  Price  Time  Units 
  131,443 2.271 15:56:10 GBX
 
Recent News
DateTimeSource
HeadlineMore ROQ News
04/02/202510:58LSEG_RNSRoquefort Therapeutics PLC Director/PDMR Shareholding
03/02/202507:00LSEG_RNSRoquefort Therapeutics PLC Share Purchase Agreement Signed - Sale of Lyramid
02/01/202514:08ALNCRoquefort Therapeutics proposes USD10 million subsidiary sale
02/01/202514:08ALNCRoquefort Therapeutics proposes USD10 million subsidiary sale
02/01/202507:00LSEG_RNSRoquefort Therapeutics PLC Proposed Sale of Midkine Portfolio
04/12/202416:00LSEG_RNSRoquefort Therapeutics PLC Director Share Distribution
07/11/202407:00LSEG_RNSRoquefort Therapeutics PLC Conversion of Convertible Loan Notes
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
03/02/202507:49PBBRoquefort a potentially exploding 2022 bio tech stock....175
07/11/202407:49PBBRoquefort Therapeutics plc targeting cancer33
22/12/202113:19PBBROQ - Watch the pumpers37
Technical Analysis for Roquefort Therapeutics Plc
Get quick technical analysis for Roquefort Therapeutics Plc.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.

Latest Roquefort Therapeutics Plc Articles